Amitriptyline and imipramine inhibit the release of acetylcholine from parasympathetic nerve terminals in the rat iris.
The electrically stimulated release of [3H]acetylcholine from the parasympathetic nerve terminals of the rat iris in vitro is increased in a dose-dependent manner by scopolamine but is decreased by the tricyclic antidepressants amitriptyline and imipramine. The increased release in the presence of scopolamine seems to be due to the blockade of a presynaptic muscarinic autoreceptor that, in the drug-free state, inhibits the release of acetylcholine. However, at drug concentrations that should have comparable antimuscarinic potency, the antidepressants inhibit the release of acetylcholine. This suggests that the anticholinergic side effects of the antidepressants may be due to the reduced release of acetylcholine from parasympathetic nerve terminals as well as a possible direct postsynaptic muscarinic receptor blocking action. Whatever the mechanism of this action, the antidepressants do not have the same effect as scopolamine at the presynaptic muscarinic autoreceptor in the rat iris.
D000109:Acetylcholine / Q000378:metabolism*; D000639:Amitriptyline / Q000494:pharmacology*; D000818:Animals; D007099:Imipramine / Q000494:pharmacology*; D007498:Iris / Q000294:innervation*; D010275:Parasympathetic Nervous System / Q000187:drug effects*; D051381:Rats; D011950:Receptors, Cholinergic / Q000187:drug effects; D012601:Scopolamine / Q000494:pharmacology
D011950:Receptors, Cholinergic; D000639:Amitriptyline; D012601:Scopolamine; D000109:Acetylcholine; D007099:Imipramine